AEWIN Presents Innovative Two-Phase Direct Liquid Cooling (2P DLC) Solution at SC25
TAIPEI, Nov. 4, 2025 /PRNewswire/ — AEWIN Technologies Co., Ltd (doing business as AEWIN), a leading provider of advanced network appliances and edge computing... Read more.
Ultra Maritime Provides Next Generation Torpedo Defence to Australia’s Hunter Class Frigates
ADELAIDE, Australia, Nov. 4, 2025 /PRNewswire/ — Ultra Maritime, the premier provider of torpedo defence and anti-submarine warfare solutions, has been... Read more.
Siemens Receives Frost & Sullivan’s 2025 Southeast Asian Data Center Infrastructure Solutions Company of the Year Recognition for Excellence in Technological Innovation and Advanced Automation
This company is recognized for combining advanced simulation, product innovation, and automation to deliver operational flexibility, sustainability, and continuous... Read more.
ICAC Commissioner makes first appearance at G20 anti-corruption meeting in South Africa to foster collaboration
HONG KONG, Nov. 4, 2025 /PRNewswire/ — ICAC Commissioner Mr Woo Ying-ming, in his capacity of President of the International Association of Anti-Corruption... Read more.
StarCharge and Jardine Engineering Corporation signed an agreement for strategic cooperation on construction of charging network and microgrids
CHANGZHOU, China, Nov. 4, 2025 /PRNewswire/ — On October 21, StarCharge and the Jardine Engineering Corporation Limited (JEC), a premier engineering expert... Read more.
Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results
MILPITAS, Calif., Nov. 4, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp” or the “Company”) (NYSE: ZEPP) today announced its unaudited... Read more.
FDA Issues Complete Response Letter for Biohaven’s VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing therapeutic potential in patients with... Read more.
Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index™ to be Presented at the San Antonio Breast Cancer Symposium
A PDF of the release can be found here HOUSTON, Nov. 4, 2025 /PRNewswire/ — Delphi Diagnostics announces the upcoming presentation of four scientific abstracts,... Read more.
Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025
-Positive data from Phase Ib study of ASC30 oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction; safe and well tolerated with only mild-to-moderate... Read more.
Heartland Forward and The Rockefeller Foundation Host “Big Bets for America” to Elevate Solutions Powering the Future
Convening in Oklahoma City brought together more than 200 stakeholders, spanning leading businesses, organizations, governments and philanthropies, focused on helping... Read more.